Viral vector systems for gene therapy.
Jolly
D
D
Viagene, Inc., San Diego, CA 92121, USA.
D000256:Adenoviridae / Q000235:genetics / Q000502:physiology; D000818:Animals; D002460:Cell Line; D003673:Defective Viruses / Q000235:genetics / Q000502:physiology; D000229:Dependovirus / Q000235:genetics / Q000502:physiology; D015967:Gene Expression Regulation, Viral; D005813:Genes, Synthetic; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000008:administration & dosage / Q000235:genetics / Q000502:physiology; D016679:Genome, Viral; D006801:Humans; D051379:Mice; D016254:Mutagenesis, Insertional; D009369:Neoplasms / Q000628:therapy*; D012190:Retroviridae / Q000235:genetics / Q000302:isolation & purification / Q000472:pathogenicity / Q000502:physiology; D012449:Safety; D018139:Simplexvirus / Q000235:genetics / Q000502:physiology; D014616:Vaccinia virus / Q000235:genetics / Q000502:physiology; D018406:Virus Physiological Phenomena; D014779:Virus Replication; D014780:Viruses / Q000235:genetics* / Q000302:isolation & purification / Q000472:pathogenicity